QA: Intelgenx Technologies Corp in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001098880_2023_Intelgenx_Technologies_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001098880, Intelgenx Technologies Corp

  xvar xval
0 AssetsCurrent 3,788,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,425,000
3 remainder_Assets 977,000
4 LiabilitiesCurrent 2,374,000
5 LiabilitiesNoncurrent 425,000
6 remainder_Liabilities 9,814,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,823,452
9 ResearchAndDevelopmentExpense 3,034,657
10 remainder_Expenses 2,686,995
11 remainder_Revenues 789,196
12 remainder_NetIncome -1,289,406
13 remainder_ComprehensiveNetIncome -753,156
  yvar yval
0 Assets 9,190,000
1 Liabilities 12,613,000
2 Expenses 10,545,104
3 Revenues 789,196
4 StockholdersEquity -3,423,000
5 NetIncome -11,045,314
6 ComprehensiveNetIncome -11,421,892
7 BaseVar 17,589,931
8 EconomicCapitalRatiobeforeLimitedLiability -1.73
9 EconomicCapitalRatio 1.11

Edgar->Model Mapping

Feature Distribution

Change over Time